BOCA RATON, FL / ACCESS Newswire / November 20, 2025 /Empyrean Medical Systems, a pioneer in next-generation radiation ...

This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated ...

JERUSALEM, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company”) (NASDAQ: DRTS, DRTSW), ...

As the holidays approach, actress and entrepreneur Tia Mowry is using her voice for something deeper than festive cheer. She ...

Men diagnosed with prostate cancer have traditionally faced two choices: do nothing and hope the tumor doesn’t grow between ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

If you've recently been diagnosed with prostate cancer, this article is for you.Being diagnosed with prostate cancer often ...

Louvain-la-Neuve, Belgium, 20 November 2025 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025. Group Overv ...

Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid ...

In B.C., a suite of new technologies is reshaping how cancer is detected, diagnosed, treated and studied. This powerful shift ...

Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...